FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087667095> ?p ?o ?g. }

• W2087667095 endingPage "297" @default.
• W2087667095 startingPage "294" @default.
• W2087667095 abstract "We conducted a phase II multicenter trial to evaluate the activity of combined gemcitabine and oxaliplatin in malignant pleural mesothelioma. Twenty-five patients were recruited between May 1999 and December 2001 and received gemcitabine 1000 mg/m2 intravenously over 30 minutes and oxaliplatin 80 mg/m2 intravenously over 3 hours on days 1 and 8 of a 21-day cycle for a maximum of 6 cycles. Eligibility criteria included an Eastern Cooperative Oncology Group performance status of 0-2 and no prior chemotherapy. Best objective responses achieved were as follows: partial response, 10 patients (40%, 95% CI, 21%-61%); stable disease, 6 patients (24%, 95% CI, 9%-45%); and progressive disease, 9 patients (36%, 95% CI, 18%-57%). Median time to disease progression was 7 months, and median survival was 13 months. One-year survival was 60% (95% CI, 31%-72%). There were 2 deaths from disease progression. Toxicity was mainly hematologic. Grade 3/4 nausea and vomiting occurred in 8% of patients, neuropathy occurred in 8% of patients, and diarrhea occurred in 4% of patients. The combination of gemcitabine and oxaliplatin was shown to be active in malignant pleural mesothelioma and to exhibit tolerable toxicity in an outpatient setting." @default.
• W2087667095 created "2016-06-24" @default.
• W2087667095 creator A5030602743 @default.
• W2087667095 creator A5032883661 @default.
• W2087667095 creator A5042200971 @default.
• W2087667095 creator A5051864484 @default.
• W2087667095 creator A5055452844 @default.
• W2087667095 creator A5056404796 @default.
• W2087667095 creator A5069590663 @default.
• W2087667095 creator A5074397827 @default.
• W2087667095 creator A5087787245 @default.
• W2087667095 date "2003-03-01" @default.
• W2087667095 modified "2023-09-27" @default.
• W2087667095 title "A Multicenter Phase II Study of Gemcitabine and Oxaliplatin for Malignant Pleural Mesothelioma" @default.
• W2087667095 cites W1897113776 @default.
• W2087667095 cites W1948574410 @default.
• W2087667095 cites W1984254136 @default.
• W2087667095 cites W2010146492 @default.
• W2087667095 cites W2050014528 @default.
• W2087667095 cites W2053847483 @default.
• W2087667095 cites W2077248800 @default.
• W2087667095 cites W2090551745 @default.
• W2087667095 cites W2125980018 @default.
• W2087667095 cites W2137953688 @default.
• W2087667095 cites W2163456861 @default.
• W2087667095 cites W2413522670 @default.
• W2087667095 cites W4245520901 @default.
• W2087667095 doi "https://doi.org/10.3816/clc.2003.n.009" @default.
• W2087667095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14609447" @default.
• W2087667095 hasPublicationYear "2003" @default.
• W2087667095 type Work @default.
• W2087667095 sameAs 2087667095 @default.
• W2087667095 citedByCount "50" @default.
• W2087667095 countsByYear W20876670952012 @default.
• W2087667095 countsByYear W20876670952013 @default.
• W2087667095 countsByYear W20876670952014 @default.
• W2087667095 countsByYear W20876670952015 @default.
• W2087667095 countsByYear W20876670952018 @default.
• W2087667095 countsByYear W20876670952019 @default.
• W2087667095 countsByYear W20876670952021 @default.
• W2087667095 crossrefType "journal-article" @default.
• W2087667095 hasAuthorship W2087667095A5030602743 @default.
• W2087667095 hasAuthorship W2087667095A5032883661 @default.
• W2087667095 hasAuthorship W2087667095A5042200971 @default.
• W2087667095 hasAuthorship W2087667095A5051864484 @default.
• W2087667095 hasAuthorship W2087667095A5055452844 @default.
• W2087667095 hasAuthorship W2087667095A5056404796 @default.
• W2087667095 hasAuthorship W2087667095A5069590663 @default.
• W2087667095 hasAuthorship W2087667095A5074397827 @default.
• W2087667095 hasAuthorship W2087667095A5087787245 @default.
• W2087667095 hasConcept C121608353 @default.
• W2087667095 hasConcept C126322002 @default.
• W2087667095 hasConcept C141071460 @default.
• W2087667095 hasConcept C142724271 @default.
• W2087667095 hasConcept C143998085 @default.
• W2087667095 hasConcept C2776694085 @default.
• W2087667095 hasConcept C2777407522 @default.
• W2087667095 hasConcept C2778822529 @default.
• W2087667095 hasConcept C2780258809 @default.
• W2087667095 hasConcept C2780580376 @default.
• W2087667095 hasConcept C2780962732 @default.
• W2087667095 hasConcept C31760486 @default.
• W2087667095 hasConcept C526805850 @default.
• W2087667095 hasConcept C71924100 @default.
• W2087667095 hasConcept C90924648 @default.
• W2087667095 hasConceptScore W2087667095C121608353 @default.
• W2087667095 hasConceptScore W2087667095C126322002 @default.
• W2087667095 hasConceptScore W2087667095C141071460 @default.
• W2087667095 hasConceptScore W2087667095C142724271 @default.
• W2087667095 hasConceptScore W2087667095C143998085 @default.
• W2087667095 hasConceptScore W2087667095C2776694085 @default.
• W2087667095 hasConceptScore W2087667095C2777407522 @default.
• W2087667095 hasConceptScore W2087667095C2778822529 @default.
• W2087667095 hasConceptScore W2087667095C2780258809 @default.
• W2087667095 hasConceptScore W2087667095C2780580376 @default.
• W2087667095 hasConceptScore W2087667095C2780962732 @default.
• W2087667095 hasConceptScore W2087667095C31760486 @default.
• W2087667095 hasConceptScore W2087667095C526805850 @default.
• W2087667095 hasConceptScore W2087667095C71924100 @default.
• W2087667095 hasConceptScore W2087667095C90924648 @default.
• W2087667095 hasIssue "5" @default.
• W2087667095 hasLocation W20876670951 @default.
• W2087667095 hasLocation W20876670952 @default.
• W2087667095 hasOpenAccess W2087667095 @default.
• W2087667095 hasPrimaryLocation W20876670951 @default.
• W2087667095 hasRelatedWork W1988053326 @default.
• W2087667095 hasRelatedWork W1991358584 @default.
• W2087667095 hasRelatedWork W2016069234 @default.
• W2087667095 hasRelatedWork W2087667095 @default.
• W2087667095 hasRelatedWork W2094785389 @default.
• W2087667095 hasRelatedWork W2100029565 @default.
• W2087667095 hasRelatedWork W2144671372 @default.
• W2087667095 hasRelatedWork W2582045368 @default.
• W2087667095 hasRelatedWork W4247775848 @default.
• W2087667095 hasRelatedWork W4308006511 @default.
• W2087667095 hasVolume "4" @default.
• W2087667095 isParatext "false" @default.
• W2087667095 isRetracted "false" @default.

• next